Table of Contents
Table 5-21: Fayette
Table 5-23: Fountain
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2000 | 1996 - 2000 | 2000 | 1996 - 2000 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 201 | 667.5 | 882 | 606.7 | 81 | 281.5 | 400 | 290.9 |
| Esophagus | 5 | 16.5** | 20 | 14.5 | * | # | 16 | 11.7** |
| Stomach | * | # | 13 | 9.0** | * | # | 6 | 3.6** |
| Colon excluding Rectum | 17 | 59.9** | 73 | 50.3 | * | # | 27 | 18.3 |
| Rectum and Rectosigmoid Junction | 6 | 19.4** | 30 | 19.9 | * | # | 1 | # |
| Liver | * | # | 8 | 5.0** | * | # | 8 | 4.9** |
| Pancreas | 5 | 14.9** | 13 | 8.5** | * | # | 26 | 17.3 |
| Lung and Bronchus | 34 | 107.3 | 169 | 115.4 | 35 | 114.9 | 149 | 104.6 |
| Melanoma of the Skin | 9 | 30.0** | 32 | 19.9 | * | # | 2 | # |
| Prostate | 59 | 204.8 | 258 | 184.0 | 8 | 35.7** | 42 | 38.7 |
| Urinary Bladder | 16 | 51.7** | 68 | 49.6 | * | # | 7 | 6.0** |
| Kidney and Renal Pelvis | 6 | 18.9** | 28 | 18.5 | * | # | 13 | 9.8** |
| Brain and Other Nervous System | * | # | 13 | 8.2** | * | # | 13 | 8.5** |
| Non-Hodgkin Lymphoma | 7 | 20.2** | 32 | 20.7 | * | # | 14 | 11.0** |
| Myeloma | * | # | 9 | 6.7** | * | # | 6 | 4.6** |
| Leukemia | * | # | 15 | 10.3** | * | # | 18 | 12.7** |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2000 | 1996 - 2000 | 2000 | 1996 - 2000 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 188 | 468.3 | 825 | 417.8 | 67 | 162.2 | 367 | 180.7 |
| Colon excluding Rectum | 16 | 37.5** | 89 | 43.1 | * | # | 33 | 15.8 |
| Rectum and Rectosigmoid Junction | 6 | 15.1** | 28 | 14.0 | * | # | 4 | # |
| Liver | * | # | 5 | 2.5** | * | # | 3 | # |
| Pancreas | 10 | 23.0** | 19 | 9.1** | * | # | 11 | 5.3** |
| Lung and Bronchus | 32 | 78.6 | 132 | 66.5 | 20 | 49.2 | 96 | 48.3 |
| Melanoma of the Skin | * | # | 22 | 11.5 | * | # | 3 | # |
| Breast | 50 | 125.9 | 257 | 131.6 | 10 | 25.1** | 67 | 33.6 |
| Cervix Uteri | * | # | 12 | 6.1** | * | # | 6 | 2.9** |
| Corpus Uteri | 10 | 25.9** | 40 | 20.4 | * | # | 4 | # |
| Ovary | 10 | 25.6** | 38 | 19.5 | * | # | 25 | 12.5 |
| Urinary Bladder | 5 | 13.0** | 22 | 10.8 | * | # | 4 | # |
| Kidney and Renal Pelvis | 6 | 14.8** | 25 | 12.3 | * | # | 8 | 3.9** |
| Brain and Other Nervous System | * | # | 7 | 3.6** | * | # | 3 | # |
| Non-Hodgkin Lymphoma | 9 | 21.6** | 27 | 13.8 | 8 | 18.8** | 18 | 8.7** |
| Myeloma | * | # | 5 | 2.5** | * | # | 8 | 3.8** |
| Leukemia | * | # | 17 | 9.0** | * | # | 15 | 7.0** |
Rates are per 100,000; Age-adjusted, 2000 U.S. Standard Million.
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, October 2004
Table of Contents
Table 5-21: Fayette
Table 5-23: Fountain
